Brief Summary

This study seeks to determine the feasibility and efficacy of a Problem Solving Therapy intervention for the treatment of late life depression (LLD). Participants diagnosed with LLD will participate in 8 weekly sessions of Problem Solving Therapy, a form of talk-therapy, over a period of eight weeks. A Case Manager (CM) trained in this therapy will lead the PST sessions. Participants will attend a clinical assessment pre and post study intervention to assess depression severity, quality of life, anxiety, insomnia, functional disability, and participant's acceptability of the intervention. Additionally self-rated depression will be collected weekly over 8 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Feb 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 24, 2018

Completed
8 days until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
Last Updated

June 11, 2019

Status Verified

June 1, 2019

Enrollment Period

1.3 years

First QC Date

January 18, 2018

Last Update Submit

June 10, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Successful implementation of Problem Solving Therapy (PST).

    The primary outcome measure will be if CM delivered PST can be successfully implemented in the London Health Sciences Centre geriatric outreach program. If the recruitment goal of n=40 is met within 1 year, and 60% of participants complete the PST program, missing no more than 3 of the 8 weekly follow-ups, the primary objective will be considered to be met.

    10 weeks

Secondary Outcomes (6)

  • Depression severity as measured by the Hamilton Depression Scale (HAM-D17)

    Week 0, week 9.

  • Quality of life as measured by the EuroQol 5 Dimension 5 level (EQ-5D-5L).

    week 0, week 9.

  • Anxiety severity as measured by the Generalized Anxiety Disorder 7-item (GAD-7) scale.

    week 0, week 9.

  • Insomnia severity as measured by the Athens Insomnia Scale.

    week 0, week 9.

  • Functional disability as measured by the World Health Organization Disability Assessment Schedule 2 (WHODAS-2).

    week 0, week 9.

  • +1 more secondary outcomes

Study Arms (1)

Problem Solving Therapy

EXPERIMENTAL

All participants will attend 8 weekly sessions of Case Manager delivered Problem Solving Therapy.

Other: Problem Solving Therapy (PST)

Interventions

Participants will attend 8 weekly session of Case Manager (CM) implemented PST, a form of group talk therapy.

Problem Solving Therapy

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be considered eligible for the study if they:
  • Are of either gender and 60 years of age or greater.
  • Reside in a community setting (either independent living environment or retirement home).
  • Meet diagnostic criteria for major depressive disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) criteria.
  • Have a Hamilton Depression Rating Scale (HAMD) 17-item total score of \>= 8 and \< 24 at baseline.
  • Have a Mini Mental Status Exam score of \>= 25.
  • Have adequate hearing and vision to be able to participate in Problem Solving Therapy, with no significant sensory impairment
  • Fluent in English both written and oral.

You may not qualify if:

  • Participants will be considered ineligible for participating in the study if they:
  • Have suicidal ideation requiring inpatient admission to hospital for stabilization.
  • Have an unstable medical condition requiring hospital admission.
  • Have a life expectancy of less than 6 months or are currently receiving palliative care.
  • Have psychotic symptoms.
  • Have a lifetime history of bipolar disorder or schizophrenia.
  • Are currently alcohol dependent or have another substance dependence.
  • Are diagnosed with moderate to severe dementia.
  • Are planning admission to a long-term care facility within next 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Centre

London, Ontario, N6A 5W9, Canada

Location

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Participants will attend 8 weekly sessions of Case Manager delivered Problem Solving Therapy.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2018

First Posted

January 24, 2018

Study Start

February 1, 2018

Primary Completion

May 31, 2019

Study Completion

May 31, 2019

Last Updated

June 11, 2019

Record last verified: 2019-06

Locations